retatrutide patent owner Who Makes Retatrutide? Company Behind the Weight Loss Drug Retatrutide Still A Year+ Away.

28 Ninety patients were included in the trial, randomized to receive ALC 1,000 mg/day (500 mg intramuscularly twice daily) during the 14-day double-blind phase

Simultaneously, dial up your physical activity (aim for 150+ minutes weekly of resistance or cardiovascular exercise), increase protein intake to 1.21.6 grams per kilogram of body weight, and establish consistent meal timing to prevent reactive overeating

This means it is considered dangerous and can be addictive and that physical and psychological addiction is possible if you take this prescription drug

While uncommon, patients with known health issues need to discuss risks with their doctor and undergo monitoring before and during treatment

Consumerlab.com's answer explains